Johnson & Johnson to Spotlight Tecnis IOL Data and Innovations at ESCRS 2025

Johnson & Johnson announced its upcoming scientific data presentations and onsite activities at the 43rd European Society of Cataract and Refractive Surgeons (ESCRS) Congress, taking place September 12116, 2025, in Copenhagen.

The company will unveil new data reinforcing the clinical performance of the Tecnis IOL platform.

Key Scientific Presentations

Visual and Refractive Outcomes in Post-Laser Vision Correction Patients

• Presenter: Mr. Stephen Stewart

• Date/Time: Sunday, September 14, 2025 | 09:15–10:45 CET
  Findings show that the new refractive partial range of field extended IOL provided a broad range of vision, minimal side effects, and high patient satisfaction in individuals with prior refractive surgery. Expanded data will include subgroup outcomes based on previous hyperopic vs. myopic corrections and results from 30 additional bilateral patients.

TECNIS PureSee IOL vs. TECNIS 1-Piece IOL: Visual Outcomes and Defocus Curves

• Presenter: Dr. Helena Noguera

• Date/Time: Monday, September 15, 2025 | 14:15–15:45 CET
  The TECNIS PureSee™ IOL demonstrated superior intermediate and near vision compared with the monofocal TECNIS™ 1-Piece IOL, while maintaining excellent distance vision and a stable defocus curve. Notably, no halos or glare were reported in either group.

Tolerance to Induced Astigmatism Across IOL Categories

• Presenter: Dr. Karolinne Rocha, M.D., Ph.D.

• Date/Time: Monday, September 15, 2025 | 09:15–10:45 CET
  Study results revealed that enhanced monofocal IOLs demonstrated better tolerance to induced oblique and against-the-rule astigmatism compared to other IOL types. Across all groups, with-the-rule astigmatism was best tolerated.

Systematic Review and Meta-Analysis: Enhanced vs. Monofocal IOLs

• Presenter: Dr. Joaquin Fernandez (E-poster)
  This review confirmed high-certainty evidence that the TECNIS Eyhance™ IOL improves intermediate and near acuity versus standard monofocal IOLs. While data on contrast sensitivity and patient-reported outcomes remain moderate to low, Eyhance continues to set the benchmark among enhanced monofocal IOLs.

Educational Forums & Industry Events

In addition to its scientific program, Johnson & Johnson will host interactive forums and symposia designed to showcase innovation and foster discussion among cataract and refractive experts. Highlights include:

• J&J Vision IOL Innovation Summit: TECNIS Odyssey & PureSee IOLs
  September 12 | 19:00–20:30 CET | Crown Plaza, Room 3

• Vision Beyond Limits: Meet the EDOF Experts
  September 13 | 10:30–11:00 CET | J&J Stand E.040, Bella Congress Centre

• Innovating Clarity: Freeform Technology for High Spectacle Independence
  September 13 | 13:00–14:00 CET | Bella Congress Centre, Room D4

• A Quest for High Spectacle Independence
  September 13 | 15:00–15:30 CET | J&J Stand E.040

• Innovating Patient Care: Clinical & Economic Advantages of Enhanced Monofocal IOLs
  September 14 | 10:30–11:00 CET | J&J Stand E.040

• TECNIS IOL Compass: Exploring Technology & Navigating Patient Care
  September 14 | 13:00–14:00 CET | Bella Congress Centre, Room D5

• Tips and Tricks for Best SILK Practices
  September 14 | 15:00–15:30 CET | J&J Stand E.040